Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
British Journal of Clinical Pharmacology|October 1, 1983
The effect of cimetidine on tolbutamide kineticsN G Dey, C M Castleden, J Ward, et al.Advances in Experimental Medicine and Biology|January 1, 1977
Purine excretion in complete adenine phosphoribosyltransferase deficiency: effect of diet and allopurinol therapyH A Simmonds, K J Van Acker, J S Cameron, et al.British Journal of Anaesthesia|August 1, 1982
Plasma concentrations of lignocaine and its metabolites during fibreoptic bronchoscopyD A Jones, A McBurney, P J Stanley, et al.Clinical Pharmacology and Therapeutics|October 1, 1985
Pharmacokinetics and beta-blocking effects of timolol in poor and extensive metabolizers of debrisoquinJ C McGourty, J H Silas, J J Fleming, et al.Investigative Radiology|July 1, 1993
Hemodialysis and iopamidol clearance after subclavian venographyP K Donnelly, N Burwell, A McBurney, et al.The British Journal of Radiology|December 1, 1992
Clearance of iopamidol, a non-ionic contrast medium, by CAPD in patients with end-stage renal failureP K Donnelly, N Burwell, A McBurney, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 26, 2002
Pharmacokinetics and metabolism of the anti-oestrogen droloxifene in female human subjectsB A John, R R Brodie, G A Baldock, et al.British Journal of Clinical Pharmacology|April 1, 1989
Variable metabolism of pinacidil: lack of correlation with the debrisoquine and trimethylamine C- and N-oxidative polymorphismsR Ayesh, M Al-Waiz, A McBurney, et al.European Journal of Drug Metabolism and Pharmacokinetics|May 21, 2004
Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dogC Webber, C A Stokes, S Persiani, et al.European Journal of Drug Metabolism and Pharmacokinetics|October 7, 2003
Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the ratC Webber, C A Stokes, S Persiani, et al.Pageof 4